|
1
|
Hajar T, Leshem YA, Hanifin JM, Nedorost
ST, Lio PA, Paller AS, Block J and Simpson EL: (The National Eczema
Association Task Force): A systematic review of topical
corticosteroid withdrawal (‘steroid addiction’) in patients with
atopic dermatitis and other dermatoses. J Am Acad Dermatol.
72(541–549): e22015.
|
|
2
|
Ghosh A, Sengupta S, Coondoo A and Jana
AK: Topical corticosteroid addiction and phobia. Indian J Dermatol.
59:465–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sheary B: Topical corticosteroid addiction
and withdrawal-An overview for GPs. Aust Fam Physician. 45:386–388.
2016.PubMed/NCBI
|
|
4
|
Luan Q, Liu L, Wei Q and Liu B: Effects of
low-level light therapy on facial corticosteroid addiction
dermatitis: A retrospective analysis of 170 Asian patients. Indian
J Dermatol Venereol Leprol. 80:1942014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu H, Xiao T, Lu B, Dong D, Yu D, Wei H
and Chen HD: Facial corticosteroid addictive dermatitis in Guiyang
City, China. Clin Exp Dermatol. 35:618–621. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goldman D: Tacrolimus ointment for the
treatment of steroid-induced rosacea: A preliminary report. J Am
Acad Dermatol. 44:995–998. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rapaport MJ and Lebwohl M: Corticosteroid
addiction and withdrawal in the atopic: The red burning skin
syndrome. Clin Dermatol. 21:201–214. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sharifi M, Koch JM, Steele RJ, Adler D,
Pompili VJ and Sopko J: Third degree AC block due to ophthalmic
timilol solution. Int J Cardiol. 80:257–259. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ng MSY, Tay YK, Ng SS, Foong AYW and Koh
MJ: Comparison of two formulations of topical timolol for the
treatment of infantile hemangiomas. Pediatr Dermatol. 34:492–493.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sushma NJ, Priyanka S and Rao J:
Neuroprotective role of melantonin against aluminum-induced
oxidative stress in the hippocampus of mouse brain. J Appl Pharm
Sci. 1:126–133. 2011.
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chinese Medical Association dermatology
branch beauty professional group: Diagnosis and treatment
guidelines of Corticosteroid addictive dermatitis. J Clin Dermatol.
38:549–550. 2009.
|
|
13
|
Jost S, Cauwerts C and Avouac P: CIE 2017
color fidelity index Rf: A better index to predict perceived color
difference? J Opt Soc Am A Opt Image Sci Vis. 35:B202–B213. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barnes L, Kaya G and Rollason V: Topical
corticosteroid-induced skin atrophy: A comprehensive review. Drug
Saf. 38:493–509. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Inoue Y, Isobe M, Shiohara T and Hayashi
H: Inhibitory activity of CX-659S, a novel diaminouracil
derivative, against the rebound phenomenon following withdrawal of
corticosteroid therapy for chronic contact hypersensitivity
responses. Int Arch Allergy Immunol. 131:143–152. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Slominski AT, Manna PR and Tuckey RC: On
the role of skin in the regulation of local and systemic
steroidogenic activities. Steroids. 103:72–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao Y and Wang J: Progress on the study
of corticosteroid addictive dermatitis. J Yunnan Med. 35:380–382.
2014.(In Chinese).
|
|
18
|
Sari E, Bakar B, Dincel GC and Yildiran
Budak FA: Effects of DMSO on a rabbit ear hypertrophic scar model:
A controlled randomized experimental study. J Plast Reconstr
Aesthet Surg. 70:509–517. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nicoli S, Padula C, Aversa V, Vietti B,
Wertz PW, Millet A, Falson F, Govoni P and Santi P:
Characterization of rabbit ear skin as a skin model for in vitro
transdermal permeation experiments: Histology, lipid composition
and permeability. Skin Pharmacol Physiol. 21:218–226. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu L, Huang HZ, Li X, Lin XX and Li W:
Open-label nonrandomized left-right comparison of imiquimod 5%
ointment and timolol maleate 0.5% eye drops in the treatment of
proliferating superficial infantile hemangioma. Dermatology.
230:150–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bhat YJ, Yaseen A and Hassan I: Topical
timolol maleate: An effectual and safe recourse for infantile
hemangiomas. Indian Dermatol Online J. 7:124–125. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aoki M, Akaishi S, Nakao J, Dohi T,
Hyakusoku H and Ogawa R: Objective spectrometric measurement of
keloid color in the East Asian population: Pitfalls of subjective
color measurements. J Nippon Med Sch. 83:142–149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takiwaki H, Miyaoka Y, Kohno H and Arase
S: Graphic analysis of the relationship between skin colour change
and variations in the amounts of melanin and haemoglobin. Skin Res
Technol. 8:78–83. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de Menonville Thibaut S, Rosignoli C,
Soares E, Roquet M, Bertino B, Chappuis JP, Defoin-Platel/Chaussade
C and Piwnica D: Topical Treatment of Rosacea with Ivermectin
Inhibits Gene Expression of Cathelicidin Innate Immune Mediators,
LL-37 and KLK5, in reconstructed and ex vivo skin models. Dermatol
Ther (Heidelb). 7:213–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marcinkiewicz M and Majewski S: The role
of antimicrobial peptides in chronic inflammatory skin diseases.
Postepy Dermatol Alergol. 33:6–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takahashi T and Gallo RL: The critical and
multifunctional roles of antimicrobial peptides in dermatology.
Dermatol Clin. 35:39–50. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sakabe J, Umayahara T, Hiroike M,
Shimauchi T, Ito T and Tokura Y: Calcipotriol increases hCAP18 mRNA
expression but inhibits extracellular LL37 peptide production in
IL17/IL22-stimulated normal human epidermal keratinocytes. Acta
Derm Venereol. 94:512–516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamasaki K, Di Nardo A, Bardan A, Murakami
M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P,
Hovnanian A, et al: Increased serine protease activity and
cathelicidin promotes skin inflammation in rosacea. Nat Med.
13:975–980. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bandurska K, Berdowska A,
Barczyńska-Felusiak R and Krupa P: Unique features of human
cathelicidin LL-37. Biofactors. 41:289–300. 2015. View Article : Google Scholar : PubMed/NCBI
|
